Monoclonal Antibody-Based Therapeutics for New Variants of Emerging Viruses
Offered By: EU Innovation Council and SMEs Executive Agency via YouTube
Course Description
Overview
Explore the cutting-edge field of monoclonal antibody-based therapeutics in this 27-minute video from the EU Innovation Council and SMEs Executive Agency. Delve into the development and application of these advanced treatments specifically designed to combat new variants of emerging viruses. Gain insights into the latest research, technological advancements, and potential impact on global health. Learn about the challenges and opportunities in creating targeted therapies that can adapt to rapidly evolving viral strains. Discover how this innovative approach is shaping the future of infectious disease management and pandemic preparedness.
Syllabus
Monoclonal antibody-based therapeutics for new variants of emerging viruses
Taught by
EU Innovation Council and SMEs Executive Agency
Related Courses
Stanford Medcast Episode 4: COVID-19 Mini-series - A Brief Overview of Monoclonal AntibodiesStanford University via Independent Respiratory & Allergy Medications - The Advanced EM Pharmacology Course
The Center for Medical Education via YouTube Working Towards an Effective Treatment for COVID-19 - The ACTIV-2 Trial by Kara Chew, MD, MS
University of California, Los Angeles via YouTube Graft-Versus-Host Disease
OPENPediatrics via YouTube Universal Influenza Vaccine Update
American Society for Microbiology via YouTube